Form 4: Valens Semiconductor Insider Trades Ordinary Shares

Valens Semiconductor Ltd. reports insider transactions involving the acquisition and sale of ordinary shares by SVP, R&D David Chairman, executed under a Rule 10b5-1 trading plan.

Summary

• David Chairman, SVP, R&D at Valens Semiconductor Ltd., engaged in transactions involving ordinary shares on April 22, 2026.
• 400 ordinary shares were acquired at a price of $0.86 per share, resulting from the exercise of stock options.
• Concurrently, 400 ordinary shares were sold at a price of $1.65 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on August 16, 2024, which is intended to satisfy affirmative defense conditions for Rule 10b5-1(c).
• Following these transactions, David Chairman beneficially owns 403,968 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transactions are routine insider activity executed under a pre-established plan and do not indicate a significant change in the executive's outlook on the company's performance.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-determined approach to insider trading.
• The acquisition of shares at a lower price ($0.86) and sale at a higher price ($1.65) on the same day suggests a profitable execution of the plan for the shares involved in this specific report.

Negatives

• The sale of shares by a key executive could be interpreted negatively by the market, although it is part of a pre-planned strategy.

Risks

• The primary risk is the potential for market misinterpretation of insider selling, even when conducted under a Rule 10b5-1 plan.
• Future fluctuations in Valens Semiconductor's stock price could impact the profitability of subsequent trades under the Rule 10b5-1 plan.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding future financial performance. However, the existence of a Rule 10b5-1 plan suggests ongoing, pre-determined trading activity by the reporting person.

Management Comments

• The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.
• The shares were acquired upon the exercise of stock options.
• The shares sold were acquired upon the exercise of stock options on the same date.
• The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common in the semiconductor industry as executives manage their personal portfolios. The execution of such plans demonstrates adherence to regulatory guidelines for managing potential conflicts of interest and insider trading perceptions.

Stakeholder Impact

• Shareholders: The sale of shares by an executive may raise questions, but the Rule 10b5-1 plan provides a framework to mitigate concerns about insider trading based on material non-public information.
• Employees: The transaction is unlikely to have a direct impact on employees, but it is part of the company's overall governance practices.
• Management: Reinforces the company's commitment to transparent insider trading policies.

Next Steps

• Continued execution of the Rule 10b5-1 trading plan by David Chairman, as per its terms.
• Monitoring of future Form 4 filings for additional insider transactions.

Key Dates

Keywords

Valens Semiconductor, VLN, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Ordinary Shares, SEC Filing, Beneficial Ownership, David Chairman